Dr Brendan Shaw is the principal of Shawview Consulting, the former CEO of Medicines Australia and assistant director-general of the International Federation of Pharmaceutical Manufacturers and Associations. In a special comment, Dr Shaw discusses the recent focus on domestic manufacturing capability.
New industrial policy for biopharmaceutical and devices industry needs careful thought
April 17, 2020 Latest NewsNews of the DayLatest Video
New Stories
-
The 'Week in Review' Podcast - 26 July
July 26, 2024 - - Podcast -
'We approached stakeholders that were highly engaged with the HTA review process'
July 26, 2024 - - Latest News -
Preaching transparency and not practising it is the worst possible look
July 26, 2024 - - Latest News -
Cartherics announces new licensing agreement for innovative cardiac cell therapy
July 25, 2024 - - Latest News -
New large study shows vaccination halves the risk of patients suffering Long-COVID
July 25, 2024 - - Latest News -
These layered levels of privilege are not making decision-making or the system better
July 25, 2024 - - Latest News -
Telix completes significant raise that could be used for acquisitions
July 25, 2024 - - Latest News